JNJ:NYSEJohnson & Johnson Analysis
Data as of 2026-09-10 - not real-time
$267.08
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $267.08, Johnson & Johnson shows a bullish moving-average alignment, with shorter averages sitting above longer ones. RSI sits at 50.3, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $255.26 up to resistance at $281.07.
Multiples put this in overvalued territory: 31.2 times earnings against the sector's 29.8. Analyst price targets sit 3.2% above the current price. Revenue is growing at 6.6% on a 21.5% profit margin. The 1.99% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 22.4%, a beta of -0.18 and a maximum drawdown of 11.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Multiples put this in overvalued territory: 31.2 times earnings against the sector's 29.8. Analyst price targets sit 3.2% above the current price. Revenue is growing at 6.6% on a 21.5% profit margin. The 1.99% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 22.4%, a beta of -0.18 and a maximum drawdown of 11.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Top Market Events
Chris Lange Tue, September 8, 2026 at 12:40 PM UTC 0 PeopleImages / Getty Images Quick Read - PepsiCo's 4% yield and...Johnson & Johnson stock trades near $268 after IMAAVY won U.Johnson & Johnson JNJ is back in focus after its stock moved higher following a 6.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 236.49
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 31.2 versus sector average of 29.8
- Trading above the 200-day average of 236.49
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 31.2 versus sector average of 29.8
- Profit margin of 21.5% is healthy
- Return on equity of 25.7%
Key Metrics & Analysis
Financial Health
Revenue Growth6.60%
Profit Margin21.48%
P/E Ratio31.2
ROE25.74%
ROA8.60%
Debt/Equity57.71
P/B Ratio7.6
Op. Cash Flow$27.6B
Free Cash Flow$16.9B
Industry P/E29.8
Technical Analysis
TrendBullish
RSI50.3
Support$255.26
Resistance$281.07
MA 20$268.99
MA 50$262.23
MA 200$236.49
MACDBearish
VolumeIncreasing
Fear & Greed Index92.02
Valuation
Fair Value$105.21
Target Price$275.64
Upside/Downside3.20%
GradeOvervalued
TypeGrowth
Dividend Yield1.99%
Risk Assessment
Beta-0.18
Volatility22.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.